Jami Giordano

Jami Giordano has extensive work experience in the pharmaceutical industry, with a focus on marketing and commercial strategy. Jami is currently serving as the Vice President of U.S. Marketing at Sage Therapeutics since October 2022. Prior to that, they worked at Alexion Pharmaceuticals, Inc. from 2020 to 2022, holding positions such as Head of U.S. Marketing, gMG Neurology, and Neurology VIsion Global Marketing and Commercial Strategy Leader. Before that, they spent several years at Ironwood Pharmaceuticals, where they held various leadership roles including Vice President - U.S. Linaclotide Franchise Lead, U.S. Brand Leader, Head of Commercial Effectiveness and Business Operations, and Senior Director of U.S. Sales Operations. Jami also worked at Sanofi as the Director of Renal U.S. Commercial Operations, Genzyme Corporation as Associate Director of Commercial Effectiveness and Development, Genzyme as Manager of Training and Development, and Ortho Biotech / Johnson and Johnson as a District Sales Manager. Jami'searlier experience includes roles at Ortho Biotech / JnJ as an Institutional Product Specialist and Nephrology Product Specialist, and at Pharmacia Corporation / Searle as a Milestone 2 Senior Sales Specialist. Jami began their career at Milestone 1 Medical as a Sales Specialist.

Jami Giordano obtained a Bachelor of Arts degree in English from Merrimack College, where they studied from 1991 to 1995.